85 related articles for article (PubMed ID: 2156989)
1. Studies of the role of membrane lipid order in the effects of delta 9-tetrahydrocannabinol on adenylate cyclase activation in heart.
Hillard CJ; Pounds JJ; Boyer DR; Bloom AS
J Pharmacol Exp Ther; 1990 Mar; 252(3):1075-82. PubMed ID: 2156989
[TBL] [Abstract][Full Text] [Related]
2. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies.
Hillard CJ; Harris RA; Bloom AS
J Pharmacol Exp Ther; 1985 Mar; 232(3):579-88. PubMed ID: 2983062
[TBL] [Abstract][Full Text] [Related]
3. Effects of delta 9-tetrahydrocannabinol on glucagon receptor coupling to adenylate cyclase in rat liver plasma membranes.
Hillard CJ; Bloom AS; Houslay MD
Biochem Pharmacol; 1986 Aug; 35(16):2797-803. PubMed ID: 3017362
[TBL] [Abstract][Full Text] [Related]
4. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
Zeiders JL; Seidler FJ; Slotkin TA
J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes.
Howlett AC; Fleming RM
Mol Pharmacol; 1984 Nov; 26(3):532-8. PubMed ID: 6092901
[TBL] [Abstract][Full Text] [Related]
6. Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices.
Reichman M; Nen W; Hokin LE
Mol Pharmacol; 1988 Dec; 34(6):823-8. PubMed ID: 2849049
[TBL] [Abstract][Full Text] [Related]
7. Desensitization in rat parotid to beta-adrenergic agonists and counteracting effects of forskolin are conserved in membrane and detergent-solubilized adenylate cyclase catalyst activity.
Harper JF
J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(3):167-76. PubMed ID: 2876014
[TBL] [Abstract][Full Text] [Related]
8. Regulation of rat heart membrane adenylate cyclase by magnesium and manganese.
Steinberg SF; Chow YK; Bilezikian JP
J Pharmacol Exp Ther; 1986 Jun; 237(3):764-72. PubMed ID: 3086539
[TBL] [Abstract][Full Text] [Related]
9. Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents.
Shook JE; Burks TF
J Pharmacol Exp Ther; 1989 May; 249(2):444-9. PubMed ID: 2542532
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of cannabinoids in the elevated plus maze.
Onaivi ES; Green MR; Martin BR
J Pharmacol Exp Ther; 1990 Jun; 253(3):1002-9. PubMed ID: 2162942
[TBL] [Abstract][Full Text] [Related]
11. Guanine nucleotide binding sites, responsible for adenylate cyclase activation and carbamylcholine binding inhibition, show similar properties in rat heart membranes.
Waelbroeck M; Robberecht P; Chatelain P; Christophe J
J Cyclic Nucleotide Res; 1981; 7(3):173-85. PubMed ID: 7287969
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.
Jeon YJ; Yang KH; Pulaski JT; Kaminski NE
Mol Pharmacol; 1996 Aug; 50(2):334-41. PubMed ID: 8700141
[TBL] [Abstract][Full Text] [Related]
13. The effect of age on adenosine A1 receptor function in the rat heart.
Gao E; Snyder DL; Johnson MD; Friedman E; Roberts J; Horwitz J
J Mol Cell Cardiol; 1997 Feb; 29(2):593-602. PubMed ID: 9140818
[TBL] [Abstract][Full Text] [Related]
14. Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain.
Tripathi HL; Vocci FJ; Brase DA; Dewey WL
Alcohol Drug Res; 1987; 7(5-6):525-32. PubMed ID: 3620017
[TBL] [Abstract][Full Text] [Related]
15. Effects of delta 9-tetrahydrocannabinol on prostaglandin formation in brain.
Reichman M; Nen W; Hokin LE
Mol Pharmacol; 1987 Nov; 32(5):686-90. PubMed ID: 2824983
[TBL] [Abstract][Full Text] [Related]
16. Multiple effects of ethanol on cardiac adenylate cyclase.
Feldman AM; Levine MA; Cates AE; Baughman KL; Van Dop C
J Cardiovasc Pharmacol; 1989 May; 13(5):774-80. PubMed ID: 2472527
[TBL] [Abstract][Full Text] [Related]
17. Modulation of rat brain opioid receptors by cannabinoids.
Vaysse PJ; Gardner EL; Zukin RS
J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic cholinergic receptor-mediated attenuation of adenylate cyclase activity in rat heart membranes.
Smith MM; Harden TK
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(2):197-210. PubMed ID: 3998232
[TBL] [Abstract][Full Text] [Related]
19. Activation of adenylate cyclase by alcohols requires the nucleotide-binding protein.
Luthin GR; Tabakoff B
J Pharmacol Exp Ther; 1984 Mar; 228(3):579-87. PubMed ID: 6707909
[TBL] [Abstract][Full Text] [Related]
20. Regulation of adenylate cyclase by cannabinoid drugs. Insights based on thermodynamic studies.
Howlett AC; Scott DK; Wilken GH
Biochem Pharmacol; 1989 Oct; 38(19):3297-304. PubMed ID: 2554920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
